As of 3:59pm ET
| +0.02 / +0.44%|
The 5 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 5.50, with a high estimate of 7.00 and a low estimate of 4.80. The median estimate represents a +21.68% increase from the last price of 4.52.
The current consensus among 6 polled investment analysts is to Buy stock in Pacific Biosciences of California Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.